Some eight months into the launch of Onapgo, the Parkinson’s disease infusion pump Supernus Pharmaceuticals spent years fighting to get across the FDA finish line, the drugmaker is discovering that ...

Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to ...

Teva Pharmaceuticals has a new game plan for raising awareness of tardive dyskinesia (TD). | Teva Pharmaceuticals has a new ...

In just its fifth full quarter on the market, the world’s first treatment for metabolic dysfunction-associated ...

Less than three months into his tenure, Novo Nordisk’s new CEO has undeniably left his mark on the company, launching a ...

The latest investment brings the British pharma’s total investment at the site in Qingdao to $886 million. AstraZeneca ...

With its biosimilars business thriving, Amgen isn’t a fan of changes proposed by HHS Secretary Robert F. Kennedy Jr. | With its biosimilars business thriving, Amgen isn’t a fan of changes proposed by ...

Katie Swicegood Fulp is a bit of a late arrival to the world of pharma marketing. | In a Q&A for Fierce Pharma Marketing’s ...

The Trump administration has spent much of this year working to coerce drugmakers into lowering their prices in the U.S. | ...

Taking a closer look at the numbers, Comirnaty sales slipped 19% globally to $1.15 billion, the Prevnar franchise experienced a 3% global sales decline to $1.7 billion, and Abrysvo’s performance ...

Eli Lilly is going for gold at the Milano Cortina 2026 Olympic and Paralympic Winter Games. | Eli Lilly is going for gold at ...

UCB has scored an FDA approval for ultra-rare disease treatment Kygevvi, continuing the positive momentum for the Belgian ...